No Data
No Data
Press Release: IntegraGen: First-Half 2024 Sales of EUR4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of EUR2.8m
IntegraGen: First-Half 2024 Sales of EUR4.5m, up 6% on the Scope Excluding SeqOIA and Cash Position of EUR2.8m -- The discontinuation of services for the SeqOIA platform mechanically led
Scope Technologies Launches Scope 2.0
Updated SaaS model empowers contractors with industry-leading roofing estimation software, roof measurement reports, and property insightsDENVER, July 18, 2024 /PRNewswire/ -- Scope Technologies
Michelin: Initiation Rating From Scope Ratings and Upgrade From Moody's Ratings
Global ESG Climate Risk Platform and Reporting Industry Research 2024: Burgeoning Opportunities in Report Validation and Verification Auditing, Scope 3 Emissions Measurements, and Data Monetization
Shuangcheng Pharma Gets Regulatory Nod to Amend Production Scope for Triptorelin Acetate Injection
Hainan Shuangcheng Pharmaceutical (SHE:002693) received approval from the drug regulator of China's Hainan Province to make changes to the production license for triptorelin acetate injection,
Photocure ASA Unveils Advanced Bladder Cancer Scope
No Data